Synonyms: | |
Status: | Approved (2015) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
UNII: | EGP8L81APK |
InChI Key | UFSKUSARDNFIRC-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C24H18F2N2O5 |
Molecular Weight | 452.41 |
AlogP | 4.75 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 97.75 |
Molecular species | ACID |
Aromatic Rings | 3.0 |
Heavy Atoms | 33.0 |
Action | Mechanism of Action | Reference |
---|---|---|
STABILISER | Cystic fibrosis transmembrane conductance regulator stabiliser | FDA |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C8
|
- | 12000 | - | - | - | |
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | 32000 | - | - | - | |
Ion channel
Other ion channel
Chloride channel
Cystic fibrosis transmembrane conductance regulator
|
2570-2600 | - | 72800 | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Cystic Fibrosis | 4 | D003550 | ClinicalTrials |
Liver Diseases | 1 | D008107 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 936727-05-8 |
ChEBI | 90951 |
ChEMBL | CHEMBL2103870 |
DrugBank | DB09280 |
DrugCentral | 5010 |
EPA CompTox | DTXSID30239523 |
FDA SRS | EGP8L81APK |
Guide to Pharmacology | 7481 |
PharmGKB | PA166114483 |
PubChem | 16678941 |
SureChEMBL | SCHEMBL377028 |
ZINC | ZINC000064033452 |